Oligonucleotide Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Oligonucleotide stocks.

Oligonucleotide Stocks Recent News

Date Stock Title
May 16 RGLS Regulus Therapeutics names Rekha Garg as chief medical officer
May 16 RGLS Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer
May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 PEPG PepGen reports Q1 results
May 14 GILD Gilead Sciences, Inc. (GILD) BofA Securities 2024 Health Care Conference (Transcript)
May 14 PEPG PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 14 GILD Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
May 14 GILD Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
May 14 PRAX We're Hopeful That Praxis Precision Medicines (NASDAQ:PRAX) Will Use Its Cash Wisely
May 13 GILD One stock is dragging down the S&P 500's earnings growth
May 13 PRAX Praxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33M
May 13 MRVI TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 13 PRQR Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
May 13 PRAX Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 11 PRQR ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
May 10 MRVI Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 PRAX Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
Oligonucleotide

Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, molecular cloning and as molecular probes. In nature, oligonucleotides are usually found as small RNA molecules that function in the regulation of gene expression (e.g. microRNA), or are degradation intermediates derived from the breakdown of larger nucleic acid molecules.
Oligonucleotides are characterized by the sequence of nucleotide residues that make up the entire molecule. The length of the oligonucleotide is usually denoted by "-mer" (from Greek meros, "part"). For example, an oligonucleotide of six nucleotides (nt) is a hexamer, while one of 25 nt would usually be called a "25-mer". Oligonucleotides readily bind, in a sequence-specific manner, to their respective complementary oligonucleotides, DNA, or RNA to form duplexes or, less often, hybrids of a higher order. This basic property serves as a foundation for the use of oligonucleotides as probes for detecting specific sequences of DNA or RNA. Examples of procedures that use oligonucleotides include DNA microarrays, Southern blots, ASO analysis, fluorescent in situ hybridization (FISH), PCR, and the synthesis of artificial genes.
Oligonucleotides are composed of 2'-deoxyribonucleotides (oligodeoxyribonucleotides), which can be modified at the backbone or on the 2’ sugar position to achieve different pharmacological effects. These modifications give new properties to the oligonucleotides and make them a key element in antisense therapy.

Browse All Tags